The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo
Clinical trial NCT02457689 · COMPLETED
Trial details
- NCT number
- NCT02457689
- Sponsor
- Imperial College London
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.